The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Aclaris Therapeutics | COMM | 00461U105 | 12,368 | 1,911,573 | SH | SOLE | 1,911,573 | 0 | 0 | ||
Akouos, Inc | ADR | 00973J101 | 30,044 | 1,515,074 | SH | SOLE | 1,515,074 | 0 | 0 | ||
Amarin Corp | ADR | 023111206 | 5,724 | 1,170,584 | SH | SOLE | 1,170,584 | 0 | 0 | ||
Ascendis Pharma A/S | ADR | 04351P101 | 185,105 | 1,109,874 | SH | SOLE | 1,109,874 | 0 | 0 | ||
Athira Pharma, Inc. | COMM | 04746L104 | 17,439 | 509,168 | SH | SOLE | 509,168 | 0 | 0 | ||
Checkmate Pharmaceuticals Inc | COMM | 162818108 | 52,622 | 3,606,707 | SH | SOLE | 3,606,707 | 0 | 0 | ||
Coherus BioSciences | COMM | 19249H103 | 7,553 | 434,555 | SH | SOLE | 434,555 | 0 | 0 | ||
Galera Therapeutics, Inc | COMM | 36338D108 | 31,546 | 3,083,712 | SH | SOLE | 3,083,712 | 0 | 0 | ||
Inozyme Pharma, Inc. | COMM | 45790W108 | 41,864 | 2,028,308 | SH | SOLE | 2,028,308 | 0 | 0 | ||
Karuna Therapeutics, Inc. | COMM | 48576A100 | 198,348 | 1,952,441 | SH | SOLE | 1,952,441 | 0 | 0 | ||
Merus N.V. | COMM | N5749R100 | 22,983 | 1,311,039 | SH | SOLE | 1,311,039 | 0 | 0 | ||
Natera | COMM | 632307104 | 308,568 | 3,100,560 | SH | SOLE | 3,100,560 | 0 | 0 | ||
Nextcure, Inc | COMM | 00653E112 | 29,123 | 2,671,856 | SH | SOLE | 2,671,856 | 0 | 0 | ||
Nucana Biomed Ltd | ADR | 67022C106 | 25,144 | 5,599,999 | SH | SOLE | 5,599,999 | 0 | 0 | ||
Nucana Biomed Ltd | Ordinary Shares | GBOOBYWYV | 10,776 | 2,400,000 | SH | SOLE | 2,400,000 | 0 | 0 | ||
ObsEva SA | COMM | H5861P103 | 9,879 | 4,749,623 | SH | SOLE | 4,749,623 | 0 | 0 | ||
PDS Biotechnology Corporation | COMM | 70465T107 | 305 | 142,635 | SH | SOLE | 142,635 | 0 | 0 | ||
Synlogic Inc. | COMM | 87166L100 | 1,242 | 574,972 | SH | SOLE | 574,972 | 0 | 0 | ||
Y-mAbs Therapeutics, Inc | COMM | 984241109 | 108,639 | 2,194,278 | SH | SOLE | 2,194,278 | 0 | 0 | ||
ACADIA Pharmaceuticals Inc | COMM | 004225108 | 8,801 | 164,625 | SH | SOLE | 164,625 | 0 | 0 | ||
Abbvie Inc | COMM | 00287Y109 | 31,459 | 293,596 | SH | SOLE | 293,596 | 0 | 0 | ||
Acceleron Pharma Inc | COMM | 00434H108 | 4,694 | 36,688 | SH | SOLE | 36,688 | 0 | 0 | ||
Aligos Therapeutics Inc | COMM | 01626L105 | 5,283 | 191,061 | SH | SOLE | 191,061 | 0 | 0 | ||
Amgen Inc | COMM | 031162100 | 37,859 | 164,663 | SH | SOLE | 164,663 | 0 | 0 | ||
Aptose Biosciences Inc | COMM | 03835T200 | 4,297 | 981,135 | SH | SOLE | 981,135 | 0 | 0 | ||
Arcus Biosciences Inc | COMM | 03969F109 | 4,836 | 186,278 | SH | SOLE | 186,278 | 0 | 0 | ||
Arena Pharmaceuticals Inc | COMM | 040047607 | 9,325 | 121,373 | SH | SOLE | 121,373 | 0 | 0 | ||
AstraZeneca PLC | ADR | 046353108 | 42,122 | 842,600 | SH | SOLE | 842,600 | 0 | 0 | ||
BioCryst Pharmaceuticals Inc | COMM | 09058V103 | 8,365 | 1,122,800 | SH | SOLE | 1,122,800 | 0 | 0 | ||
Bioatla Inc | COMM | 09077B104 | 102 | 3,000 | SH | SOLE | 3,000 | 0 | 0 | ||
Biomarin Pharmaceutical Inc | COMM | 09061G101 | 14,429 | 164,545 | SH | SOLE | 164,545 | 0 | 0 | ||
Calithera Biosciences Inc | COMM | 13089P101 | 2,457 | 500,326 | SH | SOLE | 500,326 | 0 | 0 | ||
Calithera Biosciences Inc | COMM | 13089P101 | 123 | 25,000 | SH | Call | SOLE | 25,000 | 0 | 0 | |
Calithera Biosciences Inc | COMM | 13089P101 | 737 | 150,000 | SH | Call | SOLE | 150,000 | 0 | 0 | |
Calithera Biosciences Inc | COMM | 13089P101 | 1,964 | 400,000 | SH | Put | SOLE | 400,000 | 0 | 0 | |
ChemoCentryx Inc | COMM | 16383L106 | 7,010 | 113,213 | SH | SOLE | 113,213 | 0 | 0 | ||
Cytokinetics Inc | COMM | 23282W605 | 10,564 | 508,394 | SH | SOLE | 508,394 | 0 | 0 | ||
Eli Lilly and Co | COMM | 532457108 | 6,232 | 36,909 | SH | SOLE | 36,909 | 0 | 0 | ||
Fate Therapeutics Inc | COMM | 31189P102 | 1,227 | 13,497 | SH | SOLE | 13,497 | 0 | 0 | ||
GW Pharmaceuticals PLC | ADR | 36197T103 | 11,629 | 100,762 | SH | SOLE | 100,762 | 0 | 0 | ||
Health Care Select Sector SPDR | COMM | 81369Y209 | 34,032 | 300,000 | SH | Put | SOLE | 300,000 | 0 | 0 | |
Horizon Therapeutics PLC | COMM | G46188101 | 15,609 | 213,390 | SH | SOLE | 213,390 | 0 | 0 | ||
IGM Biosciences Inc | COMM | 449585108 | 3,985 | 45,131 | SH | SOLE | 45,131 | 0 | 0 | ||
Immatics NV | COMM | N44445109 | 3,016 | 279,532 | SH | SOLE | 279,532 | 0 | 0 | ||
Insmed Inc | COMM | 457669307 | 10,309 | 309,662 | SH | SOLE | 309,662 | 0 | 0 | ||
Intra-Cellular Therapies Inc | COMM | 46116X101 | 26,972 | 848,162 | SH | SOLE | 848,162 | 0 | 0 | ||
Iovance Biotherapeutics Inc | COMM | 462260100 | 4,640 | 100,000 | SH | Put | SOLE | 100,000 | 0 | 0 | |
Jazz Pharmaceuticals PLC | COMM | G50871105 | 35,141 | 212,911 | SH | SOLE | 212,911 | 0 | 0 | ||
Jounce Therapeutics Inc | COMM | 481116101 | 6,477 | 925,280 | SH | SOLE | 925,280 | 0 | 0 | ||
Kadmon Holdings Inc | COMM | 48283N106 | 950 | 228,893 | SH | SOLE | 228,893 | 0 | 0 | ||
Kura Oncology Inc | COMM | 50127T109 | 3,941 | 120,677 | SH | SOLE | 120,677 | 0 | 0 | ||
Liquidia Corp | COMM | 53635D202 | 436 | 147,744 | SH | SOLE | 147,744 | 0 | 0 | ||
MacroGenics Inc | COMM | 556099109 | 10,488 | 458,807 | SH | SOLE | 458,807 | 0 | 0 | ||
Marinus Pharmaceuticals Inc | COMM | 56854Q200 | 3,343 | 274,027 | SH | SOLE | 274,027 | 0 | 0 | ||
Mirum Pharmaceuticals Inc | COMM | 604749101 | 7,944 | 454,974 | SH | SOLE | 454,974 | 0 | 0 | ||
Otonomy Inc | COMM | 68906L105 | 16,956 | 2,620,668 | SH | SOLE | 2,620,668 | 0 | 0 | ||
PTC Therapeutics Inc | COMM | 69366J200 | 19,315 | 316,478 | SH | SOLE | 316,478 | 0 | 0 | ||
Protagonist Therapeutics Inc | COMM | 00744E106 | 14,614 | 724,904 | SH | SOLE | 724,904 | 0 | 0 | ||
Puma Biotechnology Inc | COMM | 74587V107 | 6,460 | 629,650 | SH | SOLE | 629,650 | 0 | 0 | ||
Reata Pharmaceuticals Inc | COMM | 75615P103 | 18,412 | 148,937 | SH | SOLE | 148,937 | 0 | 0 | ||
Regenxbio Inc | COMM | 75901B107 | 12,298 | 271,114 | SH | SOLE | 271,114 | 0 | 0 | ||
Replimune Group Inc | COMM | 76029N106 | 763 | 20,000 | SH | SOLE | 20,000 | 0 | 0 | ||
Sarepta Therapeutics Inc | COMM | 803607100 | 8,840 | 51,848 | SH | SOLE | 51,848 | 0 | 0 | ||
Syndax Pharmaceuticals Inc | COMM | 87164F105 | 8,293 | 372,909 | SH | SOLE | 372,909 | 0 | 0 | ||
TCR2 Therapeutics Inc | COMM | 87808K106 | 10,322 | 333,707 | SH | SOLE | 333,707 | 0 | 0 | ||
TG Therapeutics Inc | COMM | 88322Q108 | 3,406 | 65,474 | SH | SOLE | 65,474 | 0 | 0 | ||
United Therapeutics Corp | COMM | 91307C102 | 52,808 | 347,901 | SH | SOLE | 347,901 | 0 | 0 | ||
Zogenix Inc | COMM | 98978L204 | 1,791 | 89,579 | SH | SOLE | 89,579 | 0 | 0 | ||
iShares Russell 2000 ETF | COMM | 464287655 | 25,488 | 130,000 | SH | Put | SOLE | 130,000 | 0 | 0 |